The U.S. Food and Drug Administration’s (FDA) chief counsel, Hilary Perkins, has resigned from the role just two days after her appointment, she said on March 13.
“Five days ago, I left my job as Assistant Director of the Consumer Protection Branch at the U.S. Department of Justice to begin serving at the FDA as Chief Counsel. I was honored and humbled by the trust placed in me by President Trump, Secretary Kennedy, Dr. Makary, and the rest of the Administration,” Perkins wrote in a post on her LinkedIn profile.
“Unfortunately, my work at the Department of Justice defending the FDA throughout multiple administrations—which I performed consistent with my oath to zealously advocate on behalf of the United States—created an unnecessary distraction from advancing the Administration’s priorities. With great respect for the career attorneys and professionals at FDA and with deep appreciation for my family, friends, and colleagues who have stood by me during this challenging time, I have resigned as Chief Counsel,” Perkins said….